Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial

Hope William W.; Walsh Thomas J.; Goodwin Joanne; Peloquin Charles A.; Howard Alan; Kurtzberg Joanne; Mendizabal Alan; Confer Dennis L.; Bulitta Jurgen; Baden Lindsey R.; Neely Michael N.; Wingard John R.

首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial

【24h】

Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial

机译：HSCT后伏立康唑的药代动力学：BMT CTN 0101试验的结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Voriconazole is a first-line agent for the prevention and treatment of a number of invasive fungal diseases. Relatively little is known about the relationship between drug exposure and the prevention of invasive fungal infections.

机译：伏立康唑是预防和治疗多种侵入性真菌病的一线药物。关于药物接触与预防侵入性真菌感染之间的关系知之甚少。

著录项

来源
《The Journal of Antimicrobial Chemotherapy》 |2016年第8期|共7页
作者
Hope William W.; Walsh Thomas J.; Goodwin Joanne; Peloquin Charles A.; Howard Alan; Kurtzberg Joanne; Mendizabal Alan; Confer Dennis L.; Bulitta Jurgen; Baden Lindsey R.; Neely Michael N.; Wingard John R.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial [J] . Hope William W., Walsh Thomas J., Goodwin Joanne, The Journal of Antimicrobial Chemotherapy . 2016,第8期

机译：HSCT后伏立康唑的药代动力学：BMT CTN 0101试验的结果
2. Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial [J] . Pidala Joseph, Hamadani Mehdi, Dawson Peter, Blood: The Journal of the American Society of Hematology . 2020,第2期

机译：Sirolimus的随机多中心试验VS泼尼松作为标准风险急性GVHD的初始治疗：BMT CTN 1501试验
3. Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial [J] . Pidala Joseph, Hamadani Mehdi, Dawson Peter, Blood: The Journal of the American Society of Hematology . 2020,第1期

机译：Sirolimus的随机多中心试验VS泼尼松作为标准风险急性GVHD的初始治疗：BMT CTN 1501试验
4. Clinical Trial of Recombinant Human PH20 Hyaluronidase's Effect on Subcutaneous Absorption and Pharmacokinetics of a Large Protein Molecule Therapeutic [C] . Richard C. Yocum, Daniel E. Vaughn, Deborah J. Mongiovi, Controlled Release Society Annual Meeting and Exposition . 2007

机译：重组人PH20透明质酸酶对大蛋白分子皮下吸收和药代动力学的影响的临床试验
5. Pharmacokinetics of voriconazole in horses and alpacas. [D] . Chan, Hui Min. 2008

机译：伏立康唑在马和羊驼中的药代动力学。
6. Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial [O] . William W. Hope, Thomas J. Walsh, Joanne Goodwin, -1

机译：HSCT后伏立康唑的药代动力学：BMT CTN 0101试验的结果
7. Phase II Trial of Non-Myeloablative Conditioning and Partially HLA-Mismatched (HLA-Haploidentical) Bone Marrow Transplantation (BMT) for Patients With Hematologic Malignancies: Results of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 0603 [O] . The Johns Hopkins University, Baltimore, MD ( host institution ), Fuchs, E.J., Wu, J., 2011

机译：血液恶性肿瘤患者非清髓性调节和部分HLA不匹配（HLA单倍型）骨髓移植（BMT）的II期试验：血液和骨髓移植临床试验网络（BMT CTN）协议0603的结果

Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial

摘要

著录项

相似文献

相关主题

期刊订阅